3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
45
Lung Neoplasms
29
Neoplasms
26
Colorectal Neoplasms
20
Prostatic Neoplasms
14
Hematologic Neoplasms
10
Uterine Cervical Neoplasms
9
Fatigue
9
Anxiety Disorders
8
Neoplasm Metastasis
7
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Papillomavirus Infections
6
Ovarian Neoplasms
5
Multiple Myeloma
5
Melanoma
5
Head and Neck Neoplasms
5
Gastrointestinal Neoplasms
5
Depression
5
Carcinoma, Non-Small-Cell Lung
5
Skin Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Breast Carcinoma In Situ
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Interventions
pembrolizumab
5
padeliporfin
5
Nivolumab
5
fludarabine
4
aldesleukin
4
Ipilimumab
4
Cyclophosphamide
4
atezolizumab
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Carboplatin
3
vedolizumab
2
olaparib
2
niraparib
2
motexafin gadolinium
2
cabozantinib
2
anlotinib
2
abiraterone
2
Therapeutics
2
Sunitinib
2
Standard of Care
2
Riluzole
2
Radiation Dose Hypofractionation
2
Prednisone
2
Pluvicto
2
Mitomycin
2
LDP-02
2
Infliximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Urogenital Neoplasms
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts